Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue
Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthoto...
Saved in:
Published in | British journal of nutrition Vol. 107; no. 11; pp. 1623 - 1634 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge, UK
Cambridge University Press
14.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50·3 %, compared with untreated mice at 28 d after tumour implants (2465·5 (sem 1290·4) v. 4950·9 (sem 1689·3) mm3, P < 0·001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La (P < 0·05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice (P < 0·05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. |
---|---|
AbstractList | Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50·3 %, compared with untreated mice at 28 d after tumour implants (2465·5 (sem 1290·4) v. 4950·9 (sem 1689·3) mm3, P < 0·001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La (P < 0·05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice (P < 0·05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. [PUBLICATION ABSTRACT] Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM ( La ) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50·3 %, compared with untreated mice at 28 d after tumour implants (2465·5 ( sem 1290·4) v . 4950·9 ( sem 1689·3) mm 3 , P < 0·001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La ( P < 0·05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice ( P < 0·05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50·3 %, compared with untreated mice at 28 d after tumour implants (2465·5 (SEM 1290·4) v. 4950·9 (SEM 1689·3) mm³, P<0·001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La (P<0·05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice (P<0·05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50.3 %, compared with untreated mice at 28 d after tumour implants (2465.5 (sem 1290.4) v. 4950.9 (sem 1689.3) mm3, P < 0.001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La (P < 0.05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice (P < 0.05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50·3 %, compared with untreated mice at 28 d after tumour implants (2465·5 (SEM 1290·4) v. 4950·9 (SEM 1689·3) mm³, P<0·001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La (P<0·05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice (P<0·05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We orally pre-inoculated mice with probiotics Lactobacillus acidophilus NCFM (La) for 14 d. Subcutaneous dorsal-flank tumours and segmental orthotopic colon cancers were implanted into mice using CT-26 murine colon adenocarcinoma cells. On day 28 after tumour initiation, the lamina propria of the colon, mesenteric lymph nodes (MLN) and spleen were harvested and purified for flow cytometry and mRNA analyses. We demonstrated that La pre-inoculation reduced tumour volume growth by 50·3 %, compared with untreated mice at 28 d after tumour implants (2465·5 (sem 1290·4) v. 4950·9 (sem 1689·3) mm3, P < 0·001). Inoculation with La reduced the severity of colonic carcinogenesis caused by CT-26 cells, such as level of colonic involvement and structural abnormality of epithelial/crypt damage. Moreover, La enhanced apoptosis of CT-26 cells both in dorsal-flank tumour and segmental orthotopic colon cancer, and the mean counts of apoptotic body were higher in mice pre-inoculated with La (P < 0·05) compared with untreated mice. La pre-inoculation down-regulated the CXCR4 mRNA expressions in the colon, MLN and extra-intestinal tissue, compared with untreated mice (P < 0·05). In addition, La pre-inoculation reduced the mean fluorescence index of MHC class I (H-2Dd, -Kd and -Ld) in flow cytometry analysis. Taken together, these findings suggest that probiotics La may play a role in attenuating tumour growth during CT-26 cell carcinogenesis. The down-regulated expression of CXCR4 mRNA and MHC class I, as well as increasing apoptosis in tumour tissue, indicated that La may be associated with modulating the cellular response triggered by colon carcinogenesis. |
Author | Lin, Yung-Chang Walker, W. Allan Huang, Ching-Tai Shi, Hai Ning Jung, Shih-Ming Kong, Man-Shan Chen, Chien-Chang Lin, Chun-Yen Lin, Wei-Chuan Lin, Tzou-Yien |
Author_xml | – sequence: 1 givenname: Chien-Chang surname: Chen fullname: Chen, Chien-Chang organization: 1Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chang Gung Children's Hospital, 12L, 5 Fu-Hsing Street, Kwei-Shan, Taoyuan 333, Taiwan, ROC – sequence: 2 givenname: Wei-Chuan surname: Lin fullname: Lin, Wei-Chuan organization: 1Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chang Gung Children's Hospital, 12L, 5 Fu-Hsing Street, Kwei-Shan, Taoyuan 333, Taiwan, ROC – sequence: 3 givenname: Man-Shan surname: Kong fullname: Kong, Man-Shan organization: 1Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chang Gung Children's Hospital, 12L, 5 Fu-Hsing Street, Kwei-Shan, Taoyuan 333, Taiwan, ROC – sequence: 4 givenname: Hai Ning surname: Shi fullname: Shi, Hai Ning organization: 2Mucosal Immunology Laboratory, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA – sequence: 5 givenname: W. Allan surname: Walker fullname: Walker, W. Allan organization: 2Mucosal Immunology Laboratory, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA – sequence: 6 givenname: Chun-Yen surname: Lin fullname: Lin, Chun-Yen organization: 3Department of Internal Medicine, Hepatogastroenterology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine,Taoyuan, Taiwan, ROC – sequence: 7 givenname: Ching-Tai surname: Huang fullname: Huang, Ching-Tai organization: 4Department of Internal Medicine, Infectious Disease, Chang Gung Memorial Hospital, Chang Gung University College of Medicine,Taoyuan, Taiwan, ROC – sequence: 8 givenname: Yung-Chang surname: Lin fullname: Lin, Yung-Chang organization: 5Department of Hematology/Oncology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine,Taoyuan, Taiwan, ROC – sequence: 9 givenname: Shih-Ming surname: Jung fullname: Jung, Shih-Ming organization: 6Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC – sequence: 10 givenname: Tzou-Yien surname: Lin fullname: Lin, Tzou-Yien email: pedcgl1969@gmail.com organization: 1Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chang Gung Children's Hospital, 12L, 5 Fu-Hsing Street, Kwei-Shan, Taoyuan 333, Taiwan, ROC |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25986794$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21992995$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1v1DAQhi3Uim4LP4ALsoSQuAT8kTj2Ea0oIC3tATivHMfZdeXYweOo8F_6Y-u0y4dASL14bM0z7zvjOUVHIQaL0DNKXlNC2zefCSEtpXVDKSG14vUjtKJ121RMCHaEVku6WvIn6BTgqjwlJeoxOmFUKaZUs0I3l0l77EI0s9fZxYDjgKcUOxezM4A32uTYaeO8nwGX2Mdp75b7xfr8E4Z5mpIFsIDzPMY54V2K13mPu1gOFzDY3WhDLh4x5X3McXIGm-iLkdHB2IR16LH9npOuXMgWsgsFzg5gtk_Q8aA92KeHeIa-nr_7sv5QbS7ff1y_3VSm5iJXgjNGatIuU8kSlJB6aETDSM8aRqURUnHOhoFQIY3suCZ1bZS2zEpORM_P0Kt73TL4t7n0sB0dGOu9DjbOsKWES0GYYu0DUKoEFbyhBX3xF3pVPqhMdydIiGJCyULRe8qkCJDssJ2SG3X6UaBFrd3-s-VS8_ygPHej7X9V_FxrAV4eAA1G-yGVr3bwm2uUFK1ahPjBXI9dcv3O_tnj_-xvAWzAwJc |
CODEN | BJNUAV |
CitedBy_id | crossref_primary_10_1039_C9FO01819K crossref_primary_10_1093_gastro_gox031 crossref_primary_10_1016_j_jff_2018_07_008 crossref_primary_10_1111_jam_12499 crossref_primary_10_3390_nu5061869 crossref_primary_10_3390_cancers15030863 crossref_primary_10_1007_s12275_024_00123_2 crossref_primary_10_1097_CEJ_0000000000000738 crossref_primary_10_1016_j_ejca_2021_06_051 crossref_primary_10_1186_s12935_021_01971_3 crossref_primary_10_3390_cancers15245810 crossref_primary_10_1016_j_semcancer_2021_07_013 crossref_primary_10_1007_s12602_018_9425_8 crossref_primary_10_1016_j_tice_2018_03_013 crossref_primary_10_3390_microorganisms7030066 crossref_primary_10_1080_01635581_2019_1685674 crossref_primary_10_1007_s00253_016_8005_7 crossref_primary_10_1016_j_semcancer_2017_08_007 crossref_primary_10_1038_nrgastro_2013_178 crossref_primary_10_3390_cancers15030866 crossref_primary_10_3906_sag_1504_28 crossref_primary_10_3390_jcm12072451 crossref_primary_10_1016_j_lfs_2019_116895 crossref_primary_10_1007_s11033_022_07357_6 crossref_primary_10_5812_ircmj_84683 crossref_primary_10_1002_adtp_202000168 crossref_primary_10_1080_10408398_2022_2087174 crossref_primary_10_1039_C9RA04388H crossref_primary_10_1371_journal_pone_0147960 crossref_primary_10_2174_0929867327666201026143757 crossref_primary_10_1016_j_jff_2015_08_013 crossref_primary_10_1080_01635581_2022_2108468 crossref_primary_10_5851_kosfa_2013_33_3_335 crossref_primary_10_1080_02648725_2017_1408257 crossref_primary_10_1016_j_ebiom_2024_104980 crossref_primary_10_1016_j_semcancer_2021_12_013 crossref_primary_10_1158_1940_6207_CAPR_12_0427 crossref_primary_10_1016_j_ajpath_2017_06_011 crossref_primary_10_1007_s40995_023_01460_4 crossref_primary_10_1016_j_clnu_2016_11_017 crossref_primary_10_3390_biology12010122 crossref_primary_10_1016_j_nutres_2016_11_009 crossref_primary_10_1007_s12602_012_9124_9 crossref_primary_10_1038_s41429_022_00518_6 crossref_primary_10_3389_fphar_2021_760280 crossref_primary_10_3390_biology11050757 crossref_primary_10_1002_btpr_2937 crossref_primary_10_1016_j_drudis_2019_02_009 crossref_primary_10_1155_2022_3845104 crossref_primary_10_3390_cancers15082401 crossref_primary_10_1016_j_fbio_2021_101097 crossref_primary_10_1016_j_micpath_2020_104452 crossref_primary_10_1093_nutrit_nux001 crossref_primary_10_1007_s11356_021_13569_3 crossref_primary_10_1038_s41388_020_1341_1 crossref_primary_10_3390_cancers14194909 crossref_primary_10_1515_ijfe_2019_0079 crossref_primary_10_3389_fmicb_2016_01244 crossref_primary_10_1016_j_jff_2020_104290 crossref_primary_10_1136_bmjgast_2017_000145 crossref_primary_10_1002_fsn3_864 crossref_primary_10_3389_fphar_2021_680400 crossref_primary_10_3390_nu11112718 crossref_primary_10_1038_s41575_019_0209_8 crossref_primary_10_1039_C9FO00109C crossref_primary_10_1007_s12602_017_9253_2 crossref_primary_10_1016_j_semcancer_2021_05_018 crossref_primary_10_1080_10408398_2020_1758625 crossref_primary_10_3389_fmicb_2018_00983 crossref_primary_10_3390_ijms18010197 crossref_primary_10_3389_fmicb_2024_1327464 crossref_primary_10_1007_s12038_015_9518_4 crossref_primary_10_3389_fmicb_2021_788040 crossref_primary_10_1016_j_micinf_2019_06_004 crossref_primary_10_1016_j_phrs_2019_104448 crossref_primary_10_3390_antiox12030769 crossref_primary_10_3390_jcm8101669 crossref_primary_10_1016_j_jiac_2024_02_023 crossref_primary_10_1038_s41467_024_45572_w crossref_primary_10_3390_gastroent13010006 crossref_primary_10_1002_mnfr_202000188 crossref_primary_10_1155_2023_7429949 crossref_primary_10_3389_fmicb_2022_878297 crossref_primary_10_1177_0960327119851255 crossref_primary_10_17650_1726_9784_2019_18_4_34_42 crossref_primary_10_1016_j_micpath_2020_104207 crossref_primary_10_1186_s13048_020_00668_x crossref_primary_10_3390_ijms20082051 crossref_primary_10_1590_s0100_736x2017000600009 crossref_primary_10_1038_s41598_022_13297_9 crossref_primary_10_1080_10408398_2018_1494539 crossref_primary_10_1007_s12602_023_10183_2 crossref_primary_10_1007_s11888_012_0153_2 crossref_primary_10_23736_S1121_421X_19_02631_X crossref_primary_10_3748_wjg_v25_i2_151 crossref_primary_10_3390_metabo12100895 |
Cites_doi | 10.1093/jn/129.1.77 10.1207/s15327914nc4901_3 10.1007/s00262-004-0636-3 10.1248/bpb.18.148 10.1093/jn/135.5.996 10.1074/jbc.M303716200 10.1016/S1074-7613(00)80062-X 10.1079/BJN2002633 10.1002/ijc.21261 10.1016/j.vetmic.2007.07.003 10.1016/S1286-4579(02)01544-7 10.3748/wjg.v11.i40.6330 10.1038/35065016 10.1128/AEM.61.9.3202-3207.1995 10.1093/jn/130.2.403S 10.1093/jn/136.6.1483 10.1002/jso.20785 10.1111/j.1348-0421.2002.tb02723.x 10.1084/jem.181.2.493 10.1007/s10620-008-0363-2 10.1016/j.nut.2007.12.014 10.1016/j.gtc.2007.12.008 10.3109/08910609209141296 10.1203/01.pdr.0000183660.39116.83 10.1254/jphs.FP0071498 10.4049/jimmunol.165.11.6174 10.1016/0027-5107(94)90182-1 10.1073/pnas.93.18.9759 10.1189/jlb.0605342 10.4049/jimmunol.162.5.2671 10.1002/1521-4141(200011)30:11<3089::AID-IMMU3089>3.0.CO;2-5 10.1016/j.critrevonc.2010.01.010 10.1207/S15327914NC352_9 10.1093/carcin/23.11.1953 10.1097/00002371-199807000-00006 10.1126/science.275.5303.1129 10.1002/ijc.21185 10.1046/j.1440-1622.1999.01498.x 10.1007/s10495-006-0010-3 10.1007/s394-001-8359-7 10.1158/0008-5472.CAN-04-3833 10.4142/jvs.2008.9.1.9 10.1245/s10434-010-0970-y 10.1046/j.1365-2036.2001.01027.x |
ContentType | Journal Article |
Copyright | Copyright © The Authors 2011 2015 INIST-CNRS |
Copyright_xml | – notice: Copyright © The Authors 2011 – notice: 2015 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QP 7RV 7T5 7X2 7X7 7XB 88E 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ATCPS AZQEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB0 M0K M0S M1P M2O MBDVC NAPCQ PQEST PQQKQ PQUKI Q9U 7X8 7QL 7T7 8FD C1K FR3 P64 |
DOI | 10.1017/S0007114511004934 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Immunology Abstracts Agricultural Science Collection Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database (Proquest) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Agriculture & Environmental Science Database ProQuest Central Essentials ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agriculture Science Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest research library Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Central (Alumni) MEDLINE - Academic Engineering Research Database Technology Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Bacteriology Abstracts (Microbiology B) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Agricultural Science Database CrossRef MEDLINE - Academic Engineering Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Diet & Clinical Nutrition |
DocumentTitleAlternate | C.-C. Chen et al. Probiotics inhibit colon cancer |
EISSN | 1475-2662 |
EndPage | 1634 |
ExternalDocumentID | 2718923951 10_1017_S0007114511004934 21992995 25986794 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US Taiwan |
GeographicLocations_xml | – name: Taiwan – name: United States--US |
GroupedDBID | --- -1D -2P -E. -~6 -~X .FH 09C 09E 0E1 0R~ 23N 2WC 3V. 4.4 5GY 5RE 5VS 6J9 6PF 74X 74Y 7RV 7X2 7X7 7~V 88E 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 9M5 AAAZR AABES AABWE AACJH AAEED AAFWJ AAGFV AAIKC AAKTX AAMNQ AAMNW AARAB AASVR AATID AAUIS AAUKB AAWTL AAZAQ ABBJB ABBXD ABFBI ABGDZ ABJNI ABKKG ABKMT ABMWE ABMYL ABQTM ABROB ABUWG ABWCF ABZCX ACBEK ACBMC ACCHT ACGFS ACIMK ACPRK ACQFJ ACREK ACUIJ ACUYZ ACWGA ACYZP ACZBM ACZUX ACZWT ADAZD ADBBV ADDNB ADFEC ADFRT ADGEJ ADKIL ADOCW ADVJH AEBAK AEHGV AEMTW AENEX AENGE AEPLO AEYHU AEYYC AFFUJ AFKQG AFKRA AFLOS AFLVW AFOSN AFRAH AFRIC AFUTZ AGABE AGJUD AGLWM AGOOT AHIPN AHLTW AHMBA AHQXX AHRGI AIGNW AIHIV AIOIP AISIE AJ7 AJCYY AJPFC AJQAS ALMA_UNASSIGNED_HOLDINGS ALWZO AN0 ANPSP AQJOH ARABE ATCPS ATUCA AUXHV AYIQA AZGZS AZQEC BAWUL BBLKV BENPR BHPHI BKEYQ BLZWO BMAJL BNQBC BPHCQ BRIRG BVXVI C0O CBIIA CCPQU CCQAD CFAFE CHEAL CJCSC COF CS3 DIK DOHLZ DU5 DWQXO E3Z EBS EJD EX3 F5P FYUFA GNUQQ GUQSH HCIFZ HG- HH5 HMCUK HST HZ~ I.6 I.7 IH6 IOEEP IOO IS6 I~P J36 J38 J3A JHPGK JKPOH JQKCU JVRFK KCGVB KFECR L7B L98 LHUNA LW7 M-V M0K M1P M2O M7~ NAPCQ NIKVX O9- OK1 OVD P6G PCD PQQKQ PROAC PSQYO Q2X RAMDC RCA RIG ROL RR0 S6- S6U SAAAG SJN SY4 T9M TEORI TR2 UCJ UKHRP UT1 UU6 WFFJZ WH7 WOW WQ3 WXU WXY WYP Y6R ZA5 ZMEZD ZYDXJ ~KM -1F -2V -~N .55 .GJ 08R 354 3EH 3O- 53G 6~7 AANRG AAUGY AAYJJ ABBZL ABVFV ABZUI ACETC ADOVH ADOVT AEBPU AENCP AFFNX AI. AKZCZ ALEEW ARZZG BCGOX BESQT BGHMG BJBOZ BQFHP C1A CAG CCUQV CDIZJ CFBFF CGQII EGQIC I.9 IQODW KAFGG KC5 M8. NMFBF NZEOI OHT UAP VH1 X7M ZCG ZDLDU ZGI ZJOSE ZXP ~V1 AAHBH ABVZP ABXAU ACMRT CGR CTKSN CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 7XB 8FK H94 K9. MBDVC PQEST PQUKI Q9U 7X8 7QL 7T7 8FD C1K FR3 P64 |
ID | FETCH-LOGICAL-c436t-6322040721998072968af56520d25218c689332ff0168c8b3a044c9ae2e8306d3 |
IEDL.DBID | 8C1 |
ISSN | 0007-1145 |
IngestDate | Fri Oct 25 12:24:56 EDT 2024 Thu Oct 24 22:45:48 EDT 2024 Fri Nov 08 06:52:45 EST 2024 Thu Sep 26 17:28:43 EDT 2024 Tue Oct 15 23:40:08 EDT 2024 Sun Oct 22 16:08:33 EDT 2023 Wed Mar 13 05:51:41 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Probiotics Colon carcinogenesis Lactobacillus acidophilus NCFM CT-26 cells Apoptosis Growth Lactobacillus acidophilus Carcinogenesis Tissue Colon cancer Bacteria Lactobacillaceae Intestinal disease Colon Probiotic Digestive system Gut Oral administration Malignant tumor Colonic disease Vertebrata Mammalia Intestinal cancer Digestive diseases Computerized axial tomography Cancer |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c436t-6322040721998072968af56520d25218c689332ff0168c8b3a044c9ae2e8306d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21992995 |
PQID | 1030092698 |
PQPubID | 5629 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1038602927 proquest_miscellaneous_1019616351 proquest_journals_1030092698 crossref_primary_10_1017_S0007114511004934 pubmed_primary_21992995 pascalfrancis_primary_25986794 cambridge_journals_10_1017_S0007114511004934 |
PublicationCentury | 2000 |
PublicationDate | 2012-06-14 |
PublicationDateYYYYMMDD | 2012-06-14 |
PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-14 day: 14 |
PublicationDecade | 2010 |
PublicationPlace | Cambridge, UK |
PublicationPlace_xml | – name: Cambridge, UK – name: Cambridge – name: England |
PublicationTitle | British journal of nutrition |
PublicationTitleAlternate | Br J Nutr |
PublicationYear | 2012 |
Publisher | Cambridge University Press |
Publisher_xml | – name: Cambridge University Press |
References | Scotton (S0007114511004934_ref13) 2001; 61 S0007114511004934_ref48 S0007114511004934_ref47 White (S0007114511004934_ref49) 1999; 162 S0007114511004934_ref40 S0007114511004934_ref42 S0007114511004934_ref41 S0007114511004934_ref44 S0007114511004934_ref43 S0007114511004934_ref46 S0007114511004934_ref45 Linsalata (S0007114511004934_ref33) 2005; 19 S0007114511004934_ref9 S0007114511004934_ref14 S0007114511004934_ref17 S0007114511004934_ref16 S0007114511004934_ref19 S0007114511004934_ref6 S0007114511004934_ref18 S0007114511004934_ref5 S0007114511004934_ref7 S0007114511004934_ref50 S0007114511004934_ref11 S0007114511004934_ref10 S0007114511004934_ref12 S0007114511004934_ref26 S0007114511004934_ref25 S0007114511004934_ref28 S0007114511004934_ref27 S0007114511004934_ref29 S0007114511004934_ref20 S0007114511004934_ref22 S0007114511004934_ref21 Orrhage (S0007114511004934_ref8) 2000; 26 S0007114511004934_ref2 Zeelenberg (S0007114511004934_ref15) 2003; 63 S0007114511004934_ref1 S0007114511004934_ref4 S0007114511004934_ref3 Kado (S0007114511004934_ref23) 2001; 61 S0007114511004934_ref37 Moore (S0007114511004934_ref24) 1995; 61 S0007114511004934_ref36 S0007114511004934_ref39 S0007114511004934_ref38 S0007114511004934_ref31 S0007114511004934_ref30 S0007114511004934_ref32 S0007114511004934_ref35 S0007114511004934_ref34 |
References_xml | – volume: 61 start-page: 2395 year: 2001 ident: S0007114511004934_ref23 article-title: Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice publication-title: Cancer Res contributor: fullname: Kado – ident: S0007114511004934_ref7 doi: 10.1093/jn/129.1.77 – ident: S0007114511004934_ref29 doi: 10.1207/s15327914nc4901_3 – ident: S0007114511004934_ref44 doi: 10.1007/s00262-004-0636-3 – ident: S0007114511004934_ref27 doi: 10.1248/bpb.18.148 – ident: S0007114511004934_ref34 doi: 10.1093/jn/135.5.996 – ident: S0007114511004934_ref48 doi: 10.1074/jbc.M303716200 – ident: S0007114511004934_ref41 doi: 10.1016/S1074-7613(00)80062-X – ident: S0007114511004934_ref30 doi: 10.1079/BJN2002633 – ident: S0007114511004934_ref11 doi: 10.1002/ijc.21261 – ident: S0007114511004934_ref39 doi: 10.1016/j.vetmic.2007.07.003 – ident: S0007114511004934_ref4 doi: 10.1016/S1286-4579(02)01544-7 – ident: S0007114511004934_ref37 doi: 10.3748/wjg.v11.i40.6330 – ident: S0007114511004934_ref45 doi: 10.1038/35065016 – volume: 61 start-page: 3202 year: 1995 ident: S0007114511004934_ref24 article-title: Intestinal floras of populations that have a high risk of colon cancer publication-title: Appl Environ Microbiol doi: 10.1128/AEM.61.9.3202-3207.1995 contributor: fullname: Moore – volume: 61 start-page: 4961 year: 2001 ident: S0007114511004934_ref13 article-title: Epithelial cancer cell migration: a role for chemokine receptors? publication-title: Cancer Res contributor: fullname: Scotton – ident: S0007114511004934_ref3 doi: 10.1093/jn/130.2.403S – ident: S0007114511004934_ref36 doi: 10.1093/jn/136.6.1483 – ident: S0007114511004934_ref43 doi: 10.1002/jso.20785 – ident: S0007114511004934_ref25 doi: 10.1111/j.1348-0421.2002.tb02723.x – ident: S0007114511004934_ref16 doi: 10.1084/jem.181.2.493 – ident: S0007114511004934_ref50 doi: 10.1007/s10620-008-0363-2 – ident: S0007114511004934_ref38 doi: 10.1016/j.nut.2007.12.014 – volume: 19 start-page: 989 year: 2005 ident: S0007114511004934_ref33 article-title: Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats publication-title: In Vivo contributor: fullname: Linsalata – ident: S0007114511004934_ref2 doi: 10.1016/j.gtc.2007.12.008 – ident: S0007114511004934_ref32 doi: 10.3109/08910609209141296 – volume: 63 start-page: 3833 year: 2003 ident: S0007114511004934_ref15 article-title: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases publication-title: Cancer Res contributor: fullname: Zeelenberg – ident: S0007114511004934_ref5 doi: 10.1203/01.pdr.0000183660.39116.83 – ident: S0007114511004934_ref10 doi: 10.1254/jphs.FP0071498 – ident: S0007114511004934_ref20 doi: 10.4049/jimmunol.165.11.6174 – ident: S0007114511004934_ref31 doi: 10.1016/0027-5107(94)90182-1 – ident: S0007114511004934_ref18 doi: 10.1073/pnas.93.18.9759 – ident: S0007114511004934_ref21 doi: 10.1189/jlb.0605342 – volume: 162 start-page: 2671 year: 1999 ident: S0007114511004934_ref49 article-title: Soluble class I MHC with β2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma publication-title: J Immunol doi: 10.4049/jimmunol.162.5.2671 contributor: fullname: White – ident: S0007114511004934_ref17 doi: 10.1002/1521-4141(200011)30:11<3089::AID-IMMU3089>3.0.CO;2-5 – ident: S0007114511004934_ref1 doi: 10.1016/j.critrevonc.2010.01.010 – ident: S0007114511004934_ref22 doi: 10.1207/S15327914NC352_9 – ident: S0007114511004934_ref35 doi: 10.1093/carcin/23.11.1953 – ident: S0007114511004934_ref47 doi: 10.1097/00002371-199807000-00006 – ident: S0007114511004934_ref42 doi: 10.1126/science.275.5303.1129 – ident: S0007114511004934_ref19 doi: 10.1002/ijc.21185 – ident: S0007114511004934_ref9 doi: 10.1046/j.1440-1622.1999.01498.x – volume: 26 start-page: 95 year: 2000 ident: S0007114511004934_ref8 article-title: Bifidobacteria and lactobacilli in human health publication-title: Drugs Exp Clin Res contributor: fullname: Orrhage – ident: S0007114511004934_ref26 doi: 10.1207/s15327914nc4901_3 – ident: S0007114511004934_ref40 doi: 10.1007/s10495-006-0010-3 – ident: S0007114511004934_ref6 doi: 10.1007/s394-001-8359-7 – ident: S0007114511004934_ref46 doi: 10.1158/0008-5472.CAN-04-3833 – ident: S0007114511004934_ref12 doi: 10.4142/jvs.2008.9.1.9 – ident: S0007114511004934_ref14 doi: 10.1245/s10434-010-0970-y – ident: S0007114511004934_ref28 doi: 10.1046/j.1365-2036.2001.01027.x |
SSID | ssj0008109 |
Score | 2.4532619 |
Snippet | Modulation of the cellular response by the administration of probiotic bacteria may be an effective strategy for preventing or inhibiting tumour growth. We... |
SourceID | proquest crossref pubmed pascalfrancis cambridge |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1623 |
SubjectTerms | Adenocarcinoma - metabolism Adenocarcinoma - pathology Adenocarcinoma - prevention & control Adenocarcinoma - secondary Animals Anticarcinogenic Agents - therapeutic use Apoptosis Bacteria Biological and medical sciences Carcinogenesis Cell Line, Tumor Chemokines Colonic Neoplasms - metabolism Colonic Neoplasms - pathology Colonic Neoplasms - prevention & control Colorectal cancer Cytotoxicity E coli Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Gene Expression Regulation, Neoplastic Genes, MHC Class I Laboratory animals Lactobacillus acidophilus Lymph nodes Lymphatic Metastasis - pathology Lymphatic Metastasis - prevention & control Metastasis Mice Mice, Inbred BALB C Neoplasm Proteins - genetics Neoplasm Proteins - metabolism Neoplasm Transplantation Nutrition research Nutritional Immunology Probiotics Probiotics - therapeutic use Random Allocation Receptors, CXCR4 - genetics Receptors, CXCR4 - metabolism RNA, Messenger - metabolism Splenic Neoplasms - metabolism Splenic Neoplasms - pathology Splenic Neoplasms - prevention & control Splenic Neoplasms - secondary Tumors Vertebrates: anatomy and physiology, studies on body, several organs or systems |
Title | Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue |
URI | https://www.cambridge.org/core/product/identifier/S0007114511004934/type/journal_article https://www.ncbi.nlm.nih.gov/pubmed/21992995 https://www.proquest.com/docview/1030092698 https://search.proquest.com/docview/1019616351 https://search.proquest.com/docview/1038602927 |
Volume | 107 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bjtMwELXY3RckhLhvYKkGCfGAiIgd5-InBGWrFYKCECv1rbIdZzdSSUKT_A0fy0wuLStEn1Ilbp107Jnj-Ogcxl4mKlB5LhNfGR340hjhaxMFPq4kMp2kOjYD22IZX1zKT6toNb5wa0Za5ZQT-0SdVZbekb8lO6xAiVil7-pfPrlG0e7qaKFxxE441jmi9KXzPcUj5SPFg4QQuYymXc1eMpqKK9nUkmSaIt_kvbbCjRp1p9YN_l354HPxfyDaF6TFPXZ3RJLwfgj9fXbLlQ-Y97FwLbyCUe5zA8tJbf8h-_11iyeKsrKjZRdUOdS9DhNpNcNnst4x2habTdcAHrOqvi7o83K--AJNV_ekWddA2_3E3uEKl_DtNRgMNv4sNO5qcAoA2guq2qouLJAodgmWxtYWdJkBFoOt9kmlApMLPUDbh_4Ru1yc_5hf-KM5g29lGLd-jJkg6NXVcMFG8uNxqnNEhyLIBEKC1MaIhEKR54gpU5uaUAdSWqWdcCkuU7LwMTsuq9KdMshk7IRW0uTcSuW4iWKjw4yH3IZcR5HH3uxCsx6nWLMe6GnJ-p9Ieuz1FL11PUh2HGo8uxHf3TcECddjsvLY2RTwv_ueBqPHXuwu48Sk3RZduqqjNpjcEO1G_FCbkDzAlEg89mQYTPsbIGKwUtHTwzfwjN1GDCeIvcblGTtut517jjipNTN2lKySWT8lZuzkw_ny2_c_kt0QcA |
link.rule.ids | 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagHEBCqLwDbRkkxAERkTjOwydULawW2C6XVuotsh2njbQkYZP8G34sM3nstkLsKVHixE7Gnvlsj76PsXex9GSei9iVWnmu0Jq7SoeeizOJTMWJivSQbbGKFhfi-2V4OS64NWNa5eQTe0edVYbWyD-RHJYneSSTz_Vvl1SjaHd1lNC4y-5h2Jc0MJPZLsUj8ccUDyJC9EU47Wr2lNEUXEmmlijTJOkm77gVbsWoh7Vq8Hflg87F_4FoH5Dmh-zRiCThdDD9Y3bHlk-Y86WwLbyHke5zDauJbf8p-_NzgxeKsjKjZBdUOdQ9DxNxNcOSpHe0MsV63TWAx6yqrws6X83mZ9B0dZ80axtou19YO1zhFL69Bo3GxtdCY68GpQCgvaCqrerCAJFil2Cob21AlRlgMNgol1gq0LnQB7S96Z-xi_nX89nCHcUZXCOCqHUj9ARez66GEzaiH48SlSM65F7GERIkJkIkFPA8R0yZmEQHyhPCSGW5TXCakgXP2UFZlfYlg0xElispdO4bIa2vw0irIPMD3wS-CkOHfdyaJh2HWJMO6Wlx-o8lHfZhsl5aD5Qd-wqf3LLv9glOxPXorBx2NBn8Zt1TZ3TY2-1tHJi026JKW3VUBp0bot3Q31cmIA0wyWOHvRg6064BlBgsZfhqfwPesPuL87Nluvy2-vGaPUA8xymTzRdH7KDddPYYMVOrT_qB8Rem5BDi |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dj5QwFG10NjEmxvgtuq41MT4YyUIphT4Z3d3JqitujJvsG2lL2SUZAQf4N_5Y74Uy68Y4T0ygM2W4t7en9OQcQl4nMpBlyRNfahX4XGvmKx0HPqwkCpWkSuiJbZGJ4zP--Tw-d_ynztEq55o4FuqiMfiOfB_tsALJhEz3S0eLOD1cvm9_-egghTutzk7jJtlJuIiCBdn5eJSdft_U5TR0hA-URQx5PO9xjgLSONWiaS0KqEl0Ub5SWrg2Y91pVQcPr5xcL_4PS8fpaXmP3HW4kn6YEuE-uWHrB8Q7rGxP31An_rmi2ay9_5D8_raGE1XdGGfgRZuStqMqEyo30xM04tHKVKvV0FE4Fk17WeHn7GD5lXZDO1JobUf74Sf0Ti9gQd9fUg2hh5-lnb2YfAMo7gw1fdNWhqJEdk0NZtqaqrqg8HzXykfNCig1-Af6MREekbPl0Y-DY99ZNfiGR6L3BdSFYNRag-UbipGLVJWAFVlQMAAIqRGAiyJWloAwU5PqSAWcG6kssyksWoroMVnUTW2fElpwYZmSXJeh4dKGOhZaRUUYhSYKVRx75N0mNLkbcF0-kdWS_J9IeuTtHL28nQQ8tjXeuxbfzTcYythD6fLI7hzwv_ueU9MjrzaXYZji3ouqbTNgGyh1gH3jcFubCB3BJEs88mRKpqsbQJqwlPGz7TfwktyCUZGffMq-PCe3AdwxpLWFfJcs-vVgXwCA6vWeGxl_AJmUFqs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+inoculation+of+probiotics+Lactobacillus+acidophilus+NCFM+suppresses+tumour+growth+both+in+segmental+orthotopic+colon+cancer+and+extra-intestinal+tissue&rft.jtitle=British+journal+of+nutrition&rft.au=CHEN%2C+Chien-Chang&rft.au=LIN%2C+Wei-Chuan&rft.au=KONG%2C+Man-Shan&rft.au=HAI+NING+SHI&rft.date=2012-06-14&rft.pub=Cambridge+University+Press&rft.issn=0007-1145&rft.eissn=1475-2662&rft.volume=107&rft.issue=11&rft.spage=1623&rft.epage=1634&rft_id=info:doi/10.1017%2FS0007114511004934&rft.externalDBID=n%2Fa&rft.externalDocID=25986794 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1145&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1145&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1145&client=summon |